Abstract
Patients with regular use of nonsteroidal antiinflammatory drugs (NSAIDs) appear to have a reduced mortality from colon cancer. As NSAID use is associated with gastrointestinal bleeding, endoscopic exploration of patients on NSAID may lead to more efficient screening and frequent detection of colon cancer. A case-control study was conducted among 12,304 veterans with a colon cancer diagnosed between 1988 and 1992. Four controls were matched by age, sex, and race to each case. The frequency distributions of previous discharge diagnoses in cases and controls were compared. Arterial embolism and thrombosis, spondylosis, peripheral vascular disease, angina, osteoarthrosis, and ischemic heart disease protected against future development of colon cancer. On the other hand, atrial fibrillation and flutter, as well as phlebitis and thrombophlebitis, were associated an increased occurrence of colon cancer after 5–10 years. The study contrasts diseases that are treated with aspirin with those that are treated with other anticoagulants. Both cause bleeding, but the reduced risk of colon cancer was seen only in conditions treated with aspirin. The difference between the two disease groups from the same VA patient population suggests that chronic use of NSAID truly protects against future development of colon cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A: Inhibition of development of methylnitrourea-induced rat colon tumors by indomethacin treatment. Cancer Res 41:1954–1957, 1981
Reddy BS, Maruyama H, Kelloff G: Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of colon tumor development. Cancer Res 47:5340–5346, 1987
Skinner SA, Penney AG, O'Brien PE: Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch Surg 126:1094–1097, 1991
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus JA: Treatment of colonic and rectal adenomas with sulindac in familial polyposis. N Engl J Med 328:1313–1316, 1993
Logan RFA, Little J, Hawtin PG, Hardcastle JD: Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br Med J 307:285–289, 1993
Suh O, Mettlin C, Petrelli NJ: Aspirin use, cancer, and polyps of the large bowel. Cancer 72:1171–1177, 1993
Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolle PD, Shapiro S: A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355–358, 1991
Peleg II, Maibach HT, Brown SH, Wilcoz CM: Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 154:394–399, 1994
Thun MJ, Namboodiri MM, Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1953–1956, 1991
World Health Organization. The International Classification of Diseases, 9th revision. Clinical Modification, 2nd ed. DHHS Pub. No. (PHS) 80-1260, Washington, DC, Public Health Service, US Government Printing Office, 1980
Kahn HA, Sempos CT: Statistical Methods in Epidemiology. New York, Oxford University Press, 1989, pp 56–58
Muto T, Bussey HJR, Morson BC: The evolution of cancer of the colon and rectum. Cancer 36:2251–2270, 1975
Ekbom A, Helmick C, Zack M, Adami HO: Ulcerative colitis and colorectal cancer. A population-based-study. N Engl J Med 323:1228–1233, 1990
Ekbom A, Helmick C, Zack M, Adami H-O: Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336:357–359, 1990
Bayerdörffer E, Mannes GA, Ochsenkühn T, Köpcke W, Wiebecke B, Paumgartner G: Increased risk of high risk colorectal adenomas in overweight men. Gastroenterology 104:137–144, 1993
Thun MF, Calle EE, Namboodiri MM, Flanders WD, Coates RJ, Byers T, Boffetta P, Garfinkel L, Heath CW Jr: Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 84:1491–1500, 1992
Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677–685, 1993
Tucker MA, Caggana M, Kelsey K, Coleman CN: Secondary cancers.In Cancer Medicine, 3rd ed. J. Holland, E Frei III, RC Bast, DW Kufe, DL Morton, RR Weichselbaum, (eds). Philadelphia, Lea & Febiger, 1993, pp 2402–2415
Giovannucci E, Colditz GA, Stampfer MJ: A meta-analyses of cholecystectomy and risk of colorectal cancer. Gastroenterology 105:130–141, 1993
Ekbom A, Yuen J, Adami HO, McLaughlin JK, Chow WH, Persson I, Fraumeni JF Jr: Cholecystectomy and colorectal cancer. Gastroenterology 105:142–147, 1993
Rakel RE (ed). Conn's Current Therapy 1992. Philadelphia, WB Saunders, 1992
Woodley M, Whelan A (eds). Department of Medicine, Washington University School of Medicine. Manual of Medical Therapeutics, 27th ed. Boston, Little, Brown and Company, 1992
Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787–796, 1991
Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI: Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 327:749–754, 1992
Author information
Authors and Affiliations
Additional information
Astrid D. Müller has been supported by the German Academic Exchange Service (DAAD).
Rights and permissions
About this article
Cite this article
Müller, A.D., Sonnenberg, A. & Wasserman, I.H. Diseases preceding colon cancer. Digest Dis Sci 39, 2480–2484 (1994). https://doi.org/10.1007/BF02087670
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02087670